Triapine Radiochemotherapy in Advanced Stage Cervical Cancer

Clinical ribonucleotide reductase (RNR) inhibitors have reinvigorated enthusiasm for radiochemotherapy treatment of patients with regionally advanced stage cervical cancers. About two-thirds of patients outlive their cervical cancer (1), even though up to half of their tumors retain residual microsc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunos, Charles A., Ivy, S. Percy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949312/
https://www.ncbi.nlm.nih.gov/pubmed/29868473
http://dx.doi.org/10.3389/fonc.2018.00149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949312/
https://www.ncbi.nlm.nih.gov/pubmed/29868473
http://dx.doi.org/10.3389/fonc.2018.00149

Ejemplares similares